72 independently detected trends connected to this subject, with the latest coverage first.
This hub groups 72 separate news trends connected to Oncology, spanning June 19, 2026 through September 8, 2026. Each event page combines source coverage, attention velocity and a time-stamped explanation instead of treating every headline as a separate story.
The record below represents 498 article observations and 481 source signals, led by Health, Business, Science coverage. Use it to compare how individual events emerged, spread and changed over time.
AI promises a ‘golden age’ of cancer care, offering personalized cures that could touch billions.
New Greek study links higher lung‑microplastic burden to cancer, raising alarms for patients and policymakers.
An official within the FDA's CBER overruled a review team's initial rejection of a new Replimune melanoma drug.
A non-invasive urine test has been shown in trials to identify a vast majority of bladder cancer cases.
Thyme Care secures $125 million in a Series E financing round, pushing the oncology startup's valuation past $2 billion.
Early-onset bowel cancer exhibits distinct biological and clinical features compared to cases diagnosed in older adults.
A 3 % yearly rise in prostate cancer and more late‑stage diagnoses are driving urgent calls for men over 50 to get screened.
Dolly Parton's death has sparked conversations about cancer disclosure and prevention.
Genentech's $1B bet on DualityBio's ADC technology signals a major shift in cancer treatment strategies.
6 news sources are covering this Health story right now — Archynetys is tracking how fast it spreads.
A new cancer center at Park City Hospital is set to transform cancer treatment in the Wasatch Back region
New data on prostate cancer treatment has divided physicians, with active surveillance rates rising and focal therapy use under scrutiny.
Eight studies published on August 21, 2026, suggest new hope for patients with brain tumors and another deadly cancer
An experimental vaccine is generating immune responses against pancreatic cancer in high-risk individuals, according to early clinical findings.
A study has found that a diet rich in antioxidants may significantly lower the odds of developing cervical cancer.
A new medical study establishes a correlation between daily consumption of sugary drinks and an increased risk of stomach cancer.
Medical researchers have identified previously unknown immune structures within the human skull, potentially reshaping brain cancer treatment.
Moderna's stock surged 160% after the company and Merck announced success in a late-stage melanoma vaccine trial
A new study indicates that MRI scans may eliminate the necessity for invasive biopsies in diagnosing prostate cancer for many patients.
St. Jude Children's Research Hospital has a new leader who envisions a new era in childhood cancer treatments
A new study has found that flight attendants and pilots face the highest risk of dying from radiation-linked cancers.
New research suggests that even a single instance of severe sunburn may permanently alter long-term skin health and increase cancer risk.
Medical experts and health outlets are spotlighting the vital role of early screening to combat the long-term silent progression of lung cancer.
AstraZeneca has abruptly terminated its Phase 3 trial for the lung cancer drug volrustomig, halting development after an internal review.
Bristol Myers Squibb's new multiple myeloma drug Zenbexus™ debuts as a novel treatment class, but the company faces financial pressure from generic competition.
A gastroenterologist warns of colon cancer symptoms often dismissed as signs of aging.
Cullinan and Taiho's lung cancer drug has passed a major clinical trial, setting up a potential challenge to Johnson & Johnson's market-leading treatment.
Colorectal cancer rates are rising among young adults, baffling scientists and raising alarms.
Cancer patients in Gaza face a rising death rate due to Israeli restrictions on medical access.
Two non-smokers, an 11-year-old girl and a 38-year-old woman, have been diagnosed with stage 4 lung cancer.
Research indicates AI integration could deliver 82 times the return on investment in oncology clinical trials while reshaping the drug development market.
Medical discourse is shifting focus toward non-smoking related lung cancer, highlighting environmental and domestic hazards alongside technological screening tools.
Researchers have developed an oral nanomedicine that utilizes gut microbial metabolites to boost T cell effectiveness in cancer immunotherapy.
A single blood test could revolutionize cancer detection by identifying multiple cancers earlier.
New research suggests that prostate-specific antigen levels below a certain threshold may predict prostate cancer prognosis.
Patients in Illinois and Utah are among the first to receive a new experimental drug for pancreatic cancer.
Health experts and medical organizations are highlighting the necessity of recognizing early prostate cancer symptoms to encourage timely medical screening.
Scientists have discovered a unique immune cell that sacrifices itself to fight infections.
Research identifies high glucose levels as a factor in the thickening of cancer cells' sugar shields, potentially masking them from the immune system.
Researchers at Dana-Farber have engineered a molecular glue platform that utilizes DCAF11-dependent degradation activated by glutathionylation.
Research identifies the ZFP36L2 protein as a critical molecular switch in both gut tissue regeneration and colorectal cancer progression.
A newly developed covalent PFKL activator forces cancer cells to consume excess sugar, effectively stuntng tumor growth through metabolic overload.
Researchers have created a vast library of next-generation cancer models, accelerating drug development and personalized medicine.
Lung cancer testing is evolving rapidly, with new advancements and barriers shaping patient care.
Medical advancements in pancreatic cancer treatment, specifically involving Daraxonrasib and RASolute-302 data, are expanding patient access in clinical settings.
A new study links a common dietary sugar to the spread of ovarian cancer.
Engineered bispecific antibodies are targeting B-cell lymphoma by simultaneously engaging tumor cells and activating macrophages to destroy them.
Medical reports are converging on a surge in early-onset colorectal cancer diagnoses among younger populations.
Scientists in Israel have identified that the active ingredient in Viagra may possess the capability to hinder the spread of cancer.
A mouth ulcer lasting over three weeks could be a critical warning sign for head and neck cancer.
Oncologists are raising concerns that vaping may trigger a new wave of lung cancer, challenging the perception that e-cigarettes are a safer alternative.
Research identifies fructose as a potential catalyst for cancer metastasis, prompting scrutiny of dietary sugars in oncology.
Researchers are using CRISPR gene-editing technology to re-sensitize prostate tumors to immunotherapy treatments.
Actor Tyler Mane's male breast cancer diagnosis has sparked conversations about men's health awareness
Researchers have developed a fully human antibody drug capable of halting the growth and metastasis of aggressive prostate cancer in lab models.
A leading oncologist is challenging traditional wellness norms by promoting six specific habits to increase longevity and reduce chronic illness risk.
A new blood gene test has demonstrated the ability to detect 90% of early-stage pancreatic cancers, a disease with a 13% survival rate.
6 news sources are covering this Health story right now — Archynetys is tracking how fast it spreads.
A study from Imperial College Healthcare NHS Trust indicates focal therapy for prostate cancer matches surgery and radiotherapy in efficacy.
Medical discussions are intensifying over whether GLP-1 medications like Ozempic can prevent cancer or influence oncology recovery.